AZD 6244: all 119 studies that test it
Page 2 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- AZD6244 Hydrogen Sulfate for Children With Nervous System TumorsActive, not recruitingNCT01362803Phase 1/2
- AZD6244 With Cetuximab for Solid Tumors and Colorectal CancerCompletedNCT01287130Phase 1
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- Selumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsCompletedNCT01217450Phase 1
- Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY TrialTerminatedNCT01160926Phase 1
- Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor TherapyCompletedNCT01160718Phase 2
- MEK Inhibitor and Thoracic Radiotherapy TrialCompletedNCT01146756Phase 1
- Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecCompletedNCT01116271Phase 2
- Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade GliomaActive, not recruitingNCT01089101Phase 1/2
- Selumetinib and Cixutumumab in Treating Patients With Advanced Solid MalignanciesCompletedNCT01061749Phase 1
- AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
- Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid MalignanciesCompletedNCT00710515Phase 1
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
- Phase II Efficacy Study of AZD6244 in Colorectal CancerCompletedNCT00514761Phase 2
- AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid MalignanciesActive, not recruitingNCT00463814Phase 1
- AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyCompletedNCT00372944Phase 2
- AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy RegimenCompletedNCT00372788Phase 2
- Randomised Study to Compare the Efficacy of AZD6244 vs TMZCompletedNCT00338130Phase 2
- A Study of ARRY-142886 in Patients With Advanced CancerCompletedNCT00085787Phase 1